Literature DB >> 17701348

Hypermethioninemia increases cerebral acetylcholinesterase activity and impairs memory in rats.

Francieli M Stefanello1, Siomara C Monteiro, Cristiane Matté, Emilene B S Scherer, Carlos A Netto, Angela T S Wyse.   

Abstract

In the present study we investigated the effect of chronic hypermethioninemia on rat performance in the Morris water maze task, as well as on acetylcholinesterase (AChE) activity in rat cerebral cortex. For chronic treatment, rats received subcutaneous injections of methionine (1.34-2.68 micromol/g of body weight), twice a day, from the 6th to the 28th day of age; control rats received the same volume of saline solution. Groups of rats were killed 3 h, 12 h or 30 days after the last injection of methionine to AChE assay and another group was left to recover until the 60th day of life to assess the effect of early methionine administration on reference and working spatial memory of rats. AChE activity was also determined after behavioral task. Results showed that chronic treatment with methionine did not alter reference memory when compared to saline-treated animals. In the working memory task, we observed a significant days effect with significant differences between control and methionine-treated animals. Chronic hypermethioninemia significantly increased AChE activity at 3 h, 12 h or 30 days after the last injection of methionine, as well as before or after behavioral test. The effect of acute hypermethioninemia on AChE was also evaluated. For acute treatment, 29-day-old rats received one single injection of methionine (2.68 micromol/g of body weight) or saline and were killed 1, 3 or 12 h later. Results showed that acute administration of methionine did not alter cerebral cortex AChE activity. Our findings suggest that chronic experimental hypermethioninemia caused cognitive dysfunction and an increase of AChE activity that might be related, at least in part, to the neurological problems presented by hypermethioninemic patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701348     DOI: 10.1007/s11064-007-9464-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

Review 1.  Cholinergic deficiency in Alzheimer's disease. Pathogenic model.

Authors:  L S Schneider
Journal:  Am J Geriatr Psychiatry       Date:  1998       Impact factor: 4.105

Review 2.  Cholinesterases: new roles in brain function and in Alzheimer's disease.

Authors:  Ezio Giacobini
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

3.  Phenylacetate and brain dysfunction in experimental phenylketonuria: synaptic development.

Authors:  Y H Loo; T Fulton; K Miller; H M Wisniewski
Journal:  Life Sci       Date:  1980-10-06       Impact factor: 5.037

Review 4.  Glial cell heterogeneity in the mammalian spinal cord.

Authors:  R H Miller; H Zhang; J Fok-Seang
Journal:  Perspect Dev Neurobiol       Date:  1994

5.  Place navigation impaired in rats with hippocampal lesions.

Authors:  R G Morris; P Garrud; J N Rawlins; J O'Keefe
Journal:  Nature       Date:  1982-06-24       Impact factor: 49.962

Review 6.  Applications of the Morris water maze in the study of learning and memory.

Authors:  R D'Hooge; P P De Deyn
Journal:  Brain Res Brain Res Rev       Date:  2001-08

Review 7.  Acetylcholine: a neurotransmitter for learning and memory?

Authors:  A Blokland
Journal:  Brain Res Brain Res Rev       Date:  1995-11

Review 8.  Development of enzymes of energy metabolism in the neonatal mammalian brain.

Authors:  J B Clark; T E Bates; T Cullingford; J M Land
Journal:  Dev Neurosci       Date:  1993       Impact factor: 2.984

9.  Glycine N -methyltransferase deficiency: a new patient with a novel mutation.

Authors:  P Augoustides-Savvopoulou; Z Luka; S Karyda; S P Stabler; R H Allen; K Patsiaoura; C Wagner; S H Mudd
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 10.  Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease.

Authors:  A Enz; R Amstutz; H Boddeke; G Gmelin; J Malanowski
Journal:  Prog Brain Res       Date:  1993       Impact factor: 2.453

View more
  9 in total

1.  Methionine Administration in Pregnant Rats Causes Memory Deficit in the Offspring and Alters Ultrastructure in Brain Tissue.

Authors:  Bruna Martins Schweinberger; André Felipe Rodrigues; Tiago Marcon Dos Santos; Francieli Rohden; Silvia Barbosa; Paula Rigon da Luz Soster; Wania Aparecida Partata; Maria Cristina Faccioni-Heuser; Angela T S Wyse
Journal:  Neurotox Res       Date:  2017-10-30       Impact factor: 3.911

2.  Long-term methionine exposure induces memory impairment on inhibitory avoidance task and alters acetylcholinesterase activity and expression in zebrafish (Danio rerio).

Authors:  Fernanda Cenci Vuaden; Luiz Eduardo B Savio; Angelo L Piato; Talita C Pereira; Mônica R Vianna; Maurício R Bogo; Carla D Bonan; Angela T S Wyse
Journal:  Neurochem Res       Date:  2012-03-22       Impact factor: 3.996

3.  Physical exercise reverses cognitive impairment in rats subjected to experimental hyperprolinemia.

Authors:  Andréa G K Ferreira; Emilene B Scherer; Maira J da Cunha; Fernanda R Machado; Aline A da Cunha; Jeferson S Graeff; Carlos A Netto; Angela T S Wyse
Journal:  Neurochem Res       Date:  2011-07-27       Impact factor: 3.996

4.  Effect of hypoxanthine, antioxidants and allopurinol on cholinesterase activities in rats.

Authors:  Morgahna Nathalie Wamser; Eduardo Fernandes Leite; Vinícius Vialle Ferreira; Daniela Delwing-de Lima; José Geraldo Pereira da Cruz; Angela T S Wyse; Débora Delwing-Dal Magro
Journal:  J Neural Transm (Vienna)       Date:  2013-02-12       Impact factor: 3.575

5.  Disruption of peripheral circadian timekeeping in a mouse model of Huntington's disease and its restoration by temporally scheduled feeding.

Authors:  Elizabeth S Maywood; Eloise Fraenkel; Catherine J McAllister; Nigel Wood; Akhilesh B Reddy; Michael H Hastings; A Jennifer Morton
Journal:  J Neurosci       Date:  2010-07-28       Impact factor: 6.167

6.  Chronic vascular risk factors (cholesterol, homocysteine, ethanol) impair spatial memory, decline cholinergic neurons and induce blood-brain barrier leakage in rats in vivo.

Authors:  Daniela Ehrlich; Christian Humpel
Journal:  J Neurol Sci       Date:  2012-07-20       Impact factor: 3.181

7.  Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats.

Authors:  Rajeshkumar U Koladiya; Amteshwar S Jaggi; Nirmal Singh; Bhupesh K Sharma
Journal:  BMC Pharmacol       Date:  2008-08-09

8.  Withdrawal Effects Following Methionine Exposure in Adult Zebrafish.

Authors:  Rodrigo Zanandrea; Melissa Talita Wiprich; Stefani Altenhofen; Gabriel Rubensam; Tiago Marcon Dos Santos; Angela T S Wyse; Carla Denise Bonan
Journal:  Mol Neurobiol       Date:  2020-06-12       Impact factor: 5.682

9.  Hesperidin, a citrus flavonoid, protects against l-methionine-induced hyperhomocysteinemia by abrogation of oxidative stress, endothelial dysfunction and neurotoxicity in Wistar rats.

Authors:  B Hemanth Kumar; B Dinesh Kumar; Prakash V Diwan
Journal:  Pharm Biol       Date:  2016-09-27       Impact factor: 3.503

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.